CH Term (R4)
3.4.0-ci-build - ci-build
CH
CH Term (R4)
3.4.0-ci-build - ci-build
CH
CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.4.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs | Version: 3.4.0-ci-build | |||
| Active as of 2026-05-19 | Computable Name: SwissVaccinationPlanImmunizations | |||
Copyright/Legal: CC0-1.0 |
||||
Immunization procedures for recommendations according to the vaccination plan.
References
Detailed information about the current version of this artifact, including cross-references to resources that use it, can be found here via the XIG (Cross-IG) index for FHIR specifications.
http://snomed.info/sct version Not Stated (use latest from terminology server)| Code | Display |
| 42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) |
| 76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) |
| 127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) |
| 243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) |
| 16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) |
| 314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) |
| 47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) |
| 719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
| 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
| 871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) |
| 50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) |
| 761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) |
| 39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) |
| 1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) |
| 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) |
| 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
| 72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) |
| 34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) |
| 82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) |
| 127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) |
| 281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) |
| 15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) |
| 737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) |
| 722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) |
| 67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) |
| 1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) |
| 1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) |
| 1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) |
| 1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) |
Expansion from tx.fhir.ch based on SNOMED CT Swiss Edition edition 07-Dec 2025
This value set contains 30 concepts
| System | Code | Display (en) | Inactive | status | JSON | XML |
http://snomed.info/sct | 42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) | ||||
http://snomed.info/sct | 76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) | ||||
http://snomed.info/sct | 127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) | ||||
http://snomed.info/sct | 243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) | ||||
http://snomed.info/sct | 16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) | ||||
http://snomed.info/sct | 86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) | ||||
http://snomed.info/sct | 314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) | ||||
http://snomed.info/sct | 47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) | ||||
http://snomed.info/sct | 719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) | ||||
http://snomed.info/sct | 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) | ||||
http://snomed.info/sct | 871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) | ||||
http://snomed.info/sct | 50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) | ||||
http://snomed.info/sct | 761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) | ||||
http://snomed.info/sct | 39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) | ||||
http://snomed.info/sct | 1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) | ||||
http://snomed.info/sct | 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) | inactive | inactive | ||
http://snomed.info/sct | 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) | ||||
http://snomed.info/sct | 72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) | ||||
http://snomed.info/sct | 34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) | ||||
http://snomed.info/sct | 82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) | ||||
http://snomed.info/sct | 127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) | ||||
http://snomed.info/sct | 281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) | ||||
http://snomed.info/sct | 15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) | ||||
http://snomed.info/sct | 737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) | ||||
http://snomed.info/sct | 722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) | ||||
http://snomed.info/sct | 67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) | ||||
http://snomed.info/sct | 1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) | ||||
http://snomed.info/sct | 1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) | ||||
http://snomed.info/sct | 1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) | ||||
http://snomed.info/sct | 1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) |
Additional Designations and Language Displays
| Code | Other Display (null) | Deutsch (German, de) | English (English, en) | French (fr) | Italian (it) |
| 42284007 | BCG vaccination | Bacillus-Calmette-Guerin-Impfung | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen | vaccination par le BCG | vaccinazione contro la tubercolosi |
| 76668005 | Diphtheria immunization | Impfung gegen Diphterie | Administration of vaccine product containing only Corynebacterium diphtheriae antigen | vaccination contre la diphtérie | vaccinazione contro la difterite |
| 127787002 | Haemophilus influenzae type b vaccination | Impfung gegen Haemophilus influenzae Typ b | Haemophilus influenzae type b immunisation | vaccination contre l'Haemophilus influenzae de type B | vaccinazione contro l'Haemophilus influenzae di tipo b |
| 243789007 | Hepatitis A vaccination | Hepatitis-A-Impfung | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) | immunisation hépatite A | vaccinazione contro l'epatite A |
| 16584000 | Hepatitis B vaccination | Impfung gegen Hepatitis B | Administration of vaccine product containing only Hepatitis B virus antigen | vaccination contre l'hépatite B | vaccinazione contro l'epatite B |
| 86198006 | Influenza vaccination | Grippeimpfung | Administration of vaccine product containing only Influenza virus antigen (procedure) | vaccination contre l'influenza | vaccinazione contro l'influenza |
| 314759000 | Japanese encephalitis vaccination | Verabreichung einer Impfung gegen Japan-Encephalitis-Virus | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) | vaccination contre l'encéphalite japonaise | Jvaccinazione contro l'encefalite giapponese |
| 47435007 | Measles vaccination | Impfung gegen Masern | Administration of vaccine product containing only Measles morbillivirus antigen | vaccination antirougeoleuse | vaccinazione contro il morbillo |
| 719596001 | Meningitis C vaccination | Meningitis-C-Impfung | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) | administration de vaccin contenant seulement l'antigène de Neisseria meningitis du sérogroupe C | vaccinazione contro la meningite C |
| 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens | Meningitis-A- und -C-Impfung | Meningitis A and C vaccination | vaccination contre les méningites A et C | vaccinazione contro la meningite A e C |
| 871874000 | Administration of meningitis A, C, W135 and Y vaccine | Impfung gegen Meningitis A, C, W135 und Y | Meningitis A, C, W135 and Y immunization | administration de vaccin contenant seulement les antigènes de Neisseria meningitis des sérogroupes A, C, W135 et Y | vaccinazione contro la meningite A, C, W135 e Y |
| 50583002 | Mumps vaccination | Verabreichung einer Impfung gegen Mumpsvirus | Administration of vaccine product containing only Mumps orthorubulavirus antigen | vaccination contre les oreillons | vaccinazione contro la parotite |
| 761841000 | Administration of human papilloma virus vaccine | Humanes-Papillomavirus-Impfung | Administration of vaccine product containing only human papillomavirus antigen | vaccination contre le papillomavirus humain | vaccinazione contro il virus del papilloma umano |
| 39343008 | Pertussis vaccination | Verabreichung einer Impfung gegen Bordetella pertussis | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) | vaccination contre la coqueluche | vaccinazione contro la pertosse |
| 1119368005 | Pneumococcal 7-valent conjugate immunization | 7-valente-Pneumokokken-Konjugatimpfung | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) | administration de vaccin contenant seulement les antigènes capsulaires polysaccharidiques de Streptococcus pneumoniae des sérotypes danois 4, 6B, 9V, 14, 18C, 19F et 23F | vaccinazione con vaccino coniugato eptavalente contro gli pneumococchi |
| 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens | Verabreichung einer 13-valenten Konjugatimpfung gegen Pneumokokken | Pneumococcal 13-valent immunisation | administration de vaccin contenant seulement les antigènes capsulaires polysaccharidiques de Streptococcus pneumoniae des sérotypes danois 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F et 23F | vaccinazione con vaccino coniugato 13-valente contro gli pneumococchi |
| 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens | Verabreichung einer 23-valenten Konjugatimpfung gegen Pneumokokken | Administration of pneumococcal 23-valent vaccine | administration de vaccin contenant seulement les antigènes capsulaires polysaccaridiques de Streptococcus pneumoniae des sérotypes danois 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F et 33F | vaccinazione con vaccino coniugato 23-valente contro gli pneumococchi |
| 72093006 | Poliomyelitis vaccination | Impfung gegen Kinderlähmung | Administration of vaccine product containing only Human poliovirus antigen | vaccination contre la poliomyélite | vaccinazione contro la poliomielite |
| 34631000 | Rabies vaccination | Impfung gegen Tollwut | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) | vaccination contre la rage | vaccinazione contro la rabbia |
| 82314000 | German measles vaccination | Verabreichung einer Impfung gegen Rötelnvirus | Administration of vaccine product containing only Rubella virus antigen (procedure) | vaccination contre la rubéole | vaccinazione contro la rosolia |
| 127786006 | Tetanus vaccination | Tetanus-Impfung | Administration of vaccine product containing only Clostridium tetani antigen (procedure) | vaccination contre le tétanos | vaccinazione contro il tetano |
| 281658005 | Tick-borne encephalitis vaccination | Impfung gegen FSME | Administration of vaccine product containing only Tick-borne encephalitis virus antigen | vaccination contre l'encéphalite à tiques | vaccinazione contro la meningoencefalite da zecche |
| 15483003 | Typhoid vaccination | Impfung gegen Typhus | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) | vaccination antityphoïdique | vaccinazione contro la febbre tifoidea |
| 737081007 | Administration of chickenpox vaccine | Varizellen-Zoster-Impfung gegen Windpocken | Varicella-zoster immunization for chickenpox | administration du vaccin varicelle-zona contre la varicelle | vaccinazione contro il virus varicella-zoster: solo varicella |
| 722215002 | Administration of shingles vaccine | Varizellen-Zoster-Impfung gegen Gürtelrose | Administration of vaccine product containing only Varicella-zoster virus antigen for shingles | administration du vaccin varicelle-zona contre le zona | vaccinazione contro il virus varicella-zoster: solo herpes zoster |
| 67308009 | Yellow fever vaccination | Impfung gegen Gelbfieber | Administration of vaccine product containing only Yellow fever virus antigen | vaccination contre la fièvre jaune | vaccinazione contro la febbre gialla |
| 1157107003 | 2019-nCoV non-replicating viral vector immunization | Verabreichung einer nicht replizierenden Vektorimpfung gegen Coronavirus | Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure) | administration d'un vaccin à vecteur viral recombinant non réplicatif contre la COVID-19 | vaccinazione con vaccino a vettore virale non replicante anti-COVID-19 |
| 1119350007 | Administration of SARS-CoV-2 mRNA vaccine | mRNA-Impfung gegen COVID-19 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid | administration d'un vaccin à ARNm de la COVID-19 | vaccinazione con vaccino a mRNA anti-COVID-19 |
| 1209198003 | Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 immunization | Impfung gegen die humanen Papillomaviren 6, 11, 16, 18, 31, 33, 45, 52 und 58 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) | vaccination contre le papillomavirus humain 6, 11, 16, 18, 31, 33, 45, 52 et 58 | vaccinazione contro i papillomavirus umani 6, 11, 16, 18, 31, 33, 45, 52 e 58 |
| 1162645008 | 2019-nCoV recombinant spike protein antigen vaccination | Impfung gegen COVID-19 mit rekombinanten Spike-Protein-Antigenen | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | vaccination antigénique à protéine Spike recombinante contre la COVID-19 | vaccinazione con vaccino antigenico anti-COVID-19 con proteina spike ricombinante |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |